Jones Day Reps Sanofi In $560M TargeGen Buy
Sanofi-Aventis SA said Wednesday that it would pay up to $560 million to buy biotechnology company TargeGen Inc. and commercialize one of its treatments for blood disorders....To view the full article, register now.
Already a subscriber? Click here to view full article